Skip to content
DataLookout
Menu

NCT07272655

AAR/AAR+HAR vs AAR+TAR+FET for Type A Aortic Intramural Hematoma

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 2 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 7 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Start date: Oct 1, 2026 to Jan 1, 2027 Show 4 more changesShow less
    • Eligibility criteria expanded, about 11 words
    • Primary and study completion pushed from Oct 30, 2027 to Dec 30, 2027
    • Interventions: Ascending Aorta Replacement / Ascending Aorta Plus Hemiarch Replacement (Procedure), Ascending Aorta Replacement With Total Arch… to Ascending Aorta Replacement / Ascending Aorta Plus Hemiarch Replacement (Procedure), Ascending Aorta Replacement With Total Arch…
    • Secondary endpoints: details revised at 1 of 5 entries
  2. Notable Start date: Jun 1, 2026 to Oct 1, 2026
    • Primary completion pushed from Jun 30, 2027 to Oct 30, 2027
    v6
  3. Notable Start date: Apr 1, 2026 to Jun 1, 2026
    • Primary completion pushed from Apr 30, 2027 to Jun 30, 2027
    • Secondary endpoints: 6 to 5
    • Study description shortened, about 2 words
    v5
  4. Notable Primary endpoint(s) modifiedv4 Show 5 more changesShow less
    • Enrollment increased: 300 → 400 participants
    • Interventions: Ascending Aorta / Hemiarch Replacement (Procedure), Total Arch Replacement and Frozen Elephant Trunk Replacement. (Procedure) to Ascending Aorta Replacement / Ascending Aorta Plus Hemiarch Replacement (Procedure), Ascending Aorta Replacement With Total Arch…
    • Secondary endpoints revised (6)
    • Study description expanded, about 251 words
    • Study title shortened, about 2 words
  5. Minor Enrollment target: 250 to 300v3
  6. Notable Start date: Dec 1, 2025 to Apr 1, 2026
    • Primary completion date: Apr 20, 2027 to Apr 30, 2027
    • Study completion date: Oct 20, 2027 to Oct 30, 2027
    v2
  7. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Rate of reintervention on the aortic arch or descending aorta
Timeframe: 6 to 12 months after surgery

Secondary (5)

Aortic Cross-Clamp Time
Circulatory Arrest Time
Major Adverse Cardiovascular Events (MACE)
Other perioperative complications
Total hospitalization cost

Arms and interventions

AAR/AAR+HAR GroupExperimental

Participants randomized to this group will undergo ascending aorta replacement alone or ascending aorta plus hemiarch replacement (AAR/AAR+HAR), according to the operative strategy. This procedure involves replacing the ascending aorta with or without replacement of the proximal aortic arch while preserving the distal arch and supra-aortic vessels.

AAR+TAR+FET GroupActive comparator

Participants randomized to this group will undergo ascending aorta replacement with total arch replacement and frozen elephant trunk implantation (AAR+TAR+FET). This procedure involves replacement of the entire aortic arch combined with frozen elephant trunk repair of the proximal descending aorta.

Procedures: Ascending Aorta Replacement / Ascending Aorta Plus Hemiarch Replacement, Ascending Aorta Replacement With Total Arch Replacement and Frozen Elephant Trunk